The effects of the convulsant methionine sul foximine (MSO) on the glucose pathway have been in vestigated in mouse and rat brain. The key gluconeogenic enzyme fructose-l,6-biphosphatase (FBPase) (EC 3.1.3.10 was immunostained by rat anti-FBPase anti body. The rat cortex slices were very lightly stained, al most unstained in controls. After MSO injection, there was a marked staining only in astrocytes (perikarya, pro cesses, and end feet). The activity of this enzyme also increased. MSO induced an increase of 63% in the sta bility at heating (47°C) and of 36% in the stability at pro teolysis (trypsin, 10 f,Lg/ml) of FBPase. The convulsant had no effect on the concentrations of the metabolites
Recent clinical data obtained by positron com puted tomography have underlined an unequivocal hypometabolism during the interictal period in human epilepsy. In addition, a large disturbance of the glucose metabolic pathway has been described in cerebral hemispheres during epileptic convul sions in humans (Engel et aI., 1982) . In numerous animal experiments, important disturbances of en ergy metabolism have been shown in the convul sive state (Peters and To wer, 1959; McCandless and Schwartzenburg, 1982; Johansson and Fredriksson, 1985) . As far as we know, the actual metabolic mechanism of these disturbances has not been ex plained satisfactorily. In experimental seizures, there is an increase in energy metabolism utiliza tion by the central nervous system. But the convul-related to the FBPase-phosphofructokinase step, i.e., fructose-l ,6-biphosphate, glyceraldehyde-3-phosphate, and dihydroxyacetone phosphate, before, during, or after the convulsions. These results show that the cellular site of glucose pathway impairment induced by MSO in ro dent brain is presumably the astroglial cells and that one mechanism of glycogenesis could be the reinforcement of the molecules of FBPase, which enhances gluconeo genesis. A hypothetical diagram of glucose metabolism under the effect of MSO has been proposed. Key Words: Astrocytes -Epilepsy -Fructose-l ,6-biphosphatase Gluconeogenesis-Glycogen-Methionine sulfoximine. sant methionine sulfoximine (MSO) induces an in crease in glycogen content before and after the sei zures (Folbergrova, 1973; Phelps, 1975; Berel et aI., 1977) . We have shown recently that after convul sions induced by MSO in rodents, the glycogen particles were localized exclusively in astroglial cells. The particles, which often were of a type, were very abundant in astrocyte perikarya and pro cesses and more numerous in perivascular end feet. In control rodent cortex, there were a few p-gly cogen particles only in the astrocytes. Glycogen particles have never been seen in neurons in con trols or in MSO-injected rodents . These ultrastructural results were correlated to biochemical results that showed an increase of 4.7-fold in brain glycogen content. We postulated that gluconeogenesis might account for glycogen accumulation (Hevor et aI., 1985) . But the cellular site of this gluconeogenesis has not been shown. In this article, we correlate the cellular lo calization of the key gluconeogenic enzyme fruc tose-I ,6-biphosphatase (FBPase) (EC 3.1.3. II) to that of glycogen particles in the central nervous system in MSO-treated rats and mice. Moreover, we have investigated the regulation of the glucose pathway by studying the stability of FBPase and the metabolites related to the phosphofructo kinase-FBPase step. Finally, we have summarized recent data concerning the effects of MSO on the glucose pathway in rodent central nervous system.
MATERIALS AND METHODS

Animals
Male rats of the Sprague-Dawley strain weighing 300 g and male Swiss mice of the OFI strain weighing 30 g were purchased from IFFA-Credo (Arbresle). L-Methio nine-D,L-sulfoximime (100 mg/kg Sigma, St. Louis, MO, U.S.A. ) was administered intraperitoneally. The control rodents were treated with NaCI 0.9%.
FBPase activity
MSO (100 mg/kg body weight) was dissolved in 0.2 ml isotonic sodium chloride and administered by intraperi toneal injection to mice. The controls were injected with the same volume of saline. Twenty-four hours after dosing, the animals were killed by decapitation and the brains quickly removed from the skull. For mouse brain FBPase activity, the enzyme extract was prepared as de scribed by Hevor and Gayet (1978) . One mouse cerebral cortex was used for one enzyme extract, and there were at least three independent determinations of FBPase ac tivity in saline controls or MSO-treated animals. The sta bility at heating was studied using the method of Ciara nello and Axelrod (1973) . Fractions of the enzyme extract were heated at 47°C for a variable time, then cooled and centrifuged at 18,000 g for 15 min at 4°C. The FBPase activity was measured in the supernatant as previously described (Hevor and Gayet, 1978) . The stability at pro teolysis was determined by adding trypsin (Boehringer, Mannheim) to a final concentration of 10 f.Lg/ml to frac tions of the enzyme extract and by incubating at 37°C for a variable time. The proteolysis was stopped by adding trypsin inhibitor (Sigma), and the activity of FBPase was measured as before. In these experiments, appropriate controls were included to ensure that the trypsin was completely inhibited by its inhibitor. Tr ypsin was added to the inhibitor and the mixture was added to the current medium; the measured activity was the same as for FBPase alone. The Napierian logarithm of FBPase ac tivity expressed as nanomoles of fructose-l ,6-biphos phate hydrolyzed per gram per minute was plotted as a function of time, and the slope K of the linear part of the curve was taken as the first-order degradation constant for heat and for trypsin proteolysis. The half-life was cal culated as In 2/ K.
Immunocytochemical staining
FBPase was purified from rat brain and anti-FBPase antibody raised in rabbit as described by Hevor and Gayet (1981) . Twenty-four hours after dosing, the an imals were anesthetized with diethyl oxide and then ven tilated through a Y cannula. The inhaled air contained diethyl oxide to provide a suitable anesthesia. Rats were killed and fixed by intracardiac perfusion of a phosphate buffered picric acid-paraformaldehyde mixture. Te n an imals were used, comprising four animals injected with saline for controls and six injected with MSO. For the immunocytochemical procedure, the rat brains were cut on a vibratome and the sections were successively incu bated in FBPase antiserum, sheep immunoglobulin G raised against rabbit immunoglobulin G, 3,3-diaminoben zidine, and osmium. The specificity of the antiserum was checked using (a) the preimmune serum instead of anti FBPase antibody and (b) the absorbed immune serum (120 f.Lg of FBPase per milliliter of undiluted serum). In both cases, immunostaining was absent. The sections were embedded in Araldite and treated for a conventional electron microscope study.
Metabolite determination
Fructose-I,6-biphosphate, glyceraldehyde-3-phos phate, and dihydroxyacetone phosphate were determined in mouse brain using the method of Michal and Beutler (1974) . Tw enty-four hours after dosing, the animals were killed by complete immersion in liquid nitrogen. They were brought at -300C and dissected when frozen. Cortex, brainstem, and cerebellum of 2 or 3 mice were pooled together for one determination; there were at least three independent determinations in triplicate per assay. The different brain areas were homogenized in perchloric acid and the supernatant used for metabolite determination. The auxiliary enzymes (Boehringer) glyc erol-3-phosphate dehydrogenase (final concentration 3.25 f.Lg/m\), triose phosphate isomerase (0.325 f.Lg/mi), and al dolase (6.5 f.Lg/ml) were successively added to the me dium to determine dihydroxyacetone phosphate, glycer aldehyde-3-phosphate, and fructose-I,6-biphosphate, re spectively, in the same tissue. Other experiments were carried out 4 and 8 h after dosing.
Student's t test was used for statistical comparison. The values obtained in controls and in MSO-treated an imals were compared with the unpaired and small sample test. The level of significance was at least 95% with the two-tailed procedure; t values were computed with a Hewlett Packard 9810A calculator using the HP200 pro gram.
RESULTS
The intraperitoneal injection of MSO induced in mice and rats tonic and clonic seizures of the "grand mal" type, which has been already de scribed (Wolfe and Elliot, 1962; Rizzuto and Gonatas, 1974) . These convulsions appeared 7-8 h after the administration and lasted for some hours.
FBPase staining and activity
With the immunocytochemical study at the ultra structural level, the rat cortex slices were always very lightly stained, almost unstained (Fig. lA) . When the same observations were made 24 h after administration of the convulsant, an obvious immu no staining was detected in astroglial cells and only in these cells (Fig. IB) . This staining was localized in perikarya, processes, and end feet. FBPase ac tivity also increased a great deal in cerebral cortex 24 h after dosing: 104 ± 40 nmollg tissue wet weight/min at 37°C in saline controls (number of in- dependent determinations n = 6) versus 480 ± 56 nmollg/min in MSO-treated mice (n = 6; a signifi cant increase at p < 0.01). Figure 2 shows the stability at heating and in trypsin of mouse brain FBPase. After MSO admin istration, the half-life at heating (47°C) increased by 63%, with a basal value of 6 min ( Fig. 2A) . The convulsant also induced an increase of 36% in the stability of the enzyme to trypsin (10 f,Lg/ml) , the normal value being 11.30 min (Fig. 2B) . Some in vitro experiments were carried out by adding an in creasing amount of MSO (1 f,Lmol to 10 mmol) to the enzyme extract and incubating for variable times at 37°C. In any case, no change was observed in FBPase activity.
FBPase stability
Metabolites
The contents of the glucose pathway metabolites fructose-1,6-biphosphate, glyceraldehyde-3-phos phate, and dihydroxyacetone phosphate did not J Cereb Blood Flow Me/ab, Vol. 6, No.3, 1986 change after the administration of MSO in mice (Table 1) . To look for possible changes before and during the convulsions, the concentrations of these metabolites were measured 4 and 8 h after dosing in the same areas of the central nervous system. The results were the same as before, showing that the convulsant had also no significant effect on the me tabolite contents at these periods (p < 0.05).
DISCUSSION
The results of our previous work have shown that the glycogen accumulation in MSO epilepto genic rodent brain proceeds partly from gluconeo genesis (Hevor and Gayet, 1981; Hevor et aI., 1985) . The present results shed further light on the glucose pathway in the central nervous system after MSO-induced convulsions. Since glycogen particles and FBPase staining are localized exclu sively in the same type of cells, the astroglial cells, it is likely that this enzyme, which is the last key Methionine sulfoximine (MSO) (100 mg/kg body weight) was administered by intraperitoneal injection to rodents. Twenty-four hours after dosing, animals were killed by complete immersion in liquid nitrogen. Different areas of the brain were dissected out and the metabolites determined by spectrophotometry. Results are expressed as nanomoles of metabolites per gram frozen weight (mean values gluconeogenic enzyme in glucose synthesis, is im plicated in glycogen accumulation. The enhanced gluconeogenesis may supply new molecules of glu cose for glycogen synthesis. Astrocytes are prob ably the cells in which all these events occur.
In MSO-treated animals, FBPase was more resis tant to heat and proteolysis and so was more stable than the basal enzyme. These results might show that in brain the effect of MSO on the FBPase mole cules is a reinforcement, the reflection of which is a longer half-life and a more rapid catalysis, as de scribed earlier (Hevor and Gayet, 1981) . These re sults might also indicate that the MSO-induced FBPase was less modified by the different treat- by the astrocyte (Hertz, 1965; Van Gelder, 1978; Ward, 1978) . Astrocyte normally changes this glutamate into glutamine by the catalysis of glutamine synthetase; since this enzyme is inhibited by MSO (Meister, 1978) and since glutamate con centration does not increase (Folbergrova, 1973) , the latter amino acid would be converted into a-ketoglutarate. @: The a-ketoglutarate is converted into glucose by gluconeo genesis. One step of this gluconeogenesis is catalyzed by fructose-1,6-biphosphatase (FBPase) of two kinds: (a) the new FBPase, synthesized under MSO effect; (b) the former FBPase, which has been activated (Hevor and Gayet, 1981 L maybe by phosphorylation like in liver (Riou et aI., 1977) . @: A light reduction in cyclic AMP level (Hevor and Gayet, 1979) and an increase in K+ ion level initiate an increase in glycogen synthesis as in liver (Van den Berghe et aI., 1970; Penthreath, 1982) . The blood glucose cannot be the single source for glycogen accumulation since its uptake does not change after MSO administration (Folbergrova, 1973) . @:
The glycogen in brain undergoes a relatively high turnover.
Is astrocytic glycogen metabolized in view to supply neurons with glucose? Anyway, in MSO epileptogenic rodent brain, the glycogen turnover is impaired, leading to its accumula tion. G6P, glucose-6-phosphate; F6P, fructose-6-phosphate.
J Cereb Blood Flow Met{{b, Vol. 6, No.3, 1986 ments than the basal one and so its antigenicity was better. This finding probably explains our first failure in staining the basal enzyme after glutaralde hyde fixation, which certainly damaged the FBPase. Ehrmann (1982) showed that the increase in gly cogen content induced in rodent brain by phenobar bital anesthesia was accompanied by a decrease in fructose-I,6-biphosphate, dihydroxyacetone phos phate, and glyceraldehyde-3-phosphate concentra tions. In our experiments, the concentrations of these metabolites did not change before, during, or after the convulsions induced by MSO. Probably, they are not the regulation factors of the enhanced gluconeogenesis induced by the convulsant.
At this stage in our research on MSO effects on the glucose pathway in rodent CNS and liver, we can try to summarize our hypothesis of the com partmentalization of glycogenesis after convulsions in diagrammatic form (see Fig. 3 ). It is obvious that there are many points of this diagram that need fur ther experimental study.
